DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Poynard T, Marcellin P, Lee SS. et al; International Hepatitis Interventional Therapy Group (IHIT).
Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus.
Lancet 1998;
352 (9138): 1426-1432
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.